Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1238
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial ; volume:47 ; number:11 ; day:5 ; month:10 ; year:2021 ; pages:1258-1270 ; date:11.2021
Intensive care medicine ; 47, Heft 11 (5.10.2021), 1258-1270, 11.2021
- Urheber
-
Rosas, Ivan O.
Diaz, George
Gottlieb, Robert L.
Lobo, Suzana M.
Robinson, Philip
Hunter, Bradley D.
Cavalcante, Adilson W.
Overcash, J. Scott
Hanania, Nicola A.
Skarbnik, Alan
Garcia-Diaz, Julia
Gordeev, Ivan
Carratalà, Jordi
Gordon, Oliver
Graham, Emily
Lewin-Koh, Nicholas
Tsai, Larry
Tuckwell, Katie
Cao, Huyen
Brainard, Diana
Olsson, Julie K.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00134-021-06507-x
- URN
-
urn:nbn:de:101:1-2022011519251986901335
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rosas, Ivan O.
- Diaz, George
- Gottlieb, Robert L.
- Lobo, Suzana M.
- Robinson, Philip
- Hunter, Bradley D.
- Cavalcante, Adilson W.
- Overcash, J. Scott
- Hanania, Nicola A.
- Skarbnik, Alan
- Garcia-Diaz, Julia
- Gordeev, Ivan
- Carratalà, Jordi
- Gordon, Oliver
- Graham, Emily
- Lewin-Koh, Nicholas
- Tsai, Larry
- Tuckwell, Katie
- Cao, Huyen
- Brainard, Diana
- Olsson, Julie K.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Factors determining the outcome of children hospitalized with severe pneumonia
Respiratory viruses from hospitalized children with severe pneumonia in the Philippines
Age-specific risk factors of severe pneumonia among pediatric patients hospitalized with community-acquired pneumonia
Use of intravenous tocilizumab in pregnancy for severe coronavirus disease 2019 pneumonia: two case reports
Changing patterns and clinical outcomes of hospitalized patients with COVID-19 severe pneumonia treated with remdesivir according to vaccination status: results from a real-world retrospective study
Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients
Tocilizumab improves 28-day survival in hospitalized patients with severe COVID-19: an open label, prospective study
Tocilizumab for severe COVID-19 pneumonia: Experience from 5 geriatric Chinese patients with 6 months follow-up
Correction to: Changing patterns and clinical outcomes of hospitalized patients with COVID‑19 severe pneumonia treated with remdesivir according to vaccination status: results from a real‑world retrospective study
Validation of risk scores for prediction of severe pneumonia in kidney transplant recipients hospitalized with community-acquired pneumonia
Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience
A Case Series of Severe Hospitalized COVID-19 Patients Treated with Tocilizumab and Glucocorticoids: A Report from Saudi Arabian Hospital
Factors determining the outcome of children hospitalized with severe pneumonia
Respiratory viruses from hospitalized children with severe pneumonia in the Philippines
Age-specific risk factors of severe pneumonia among pediatric patients hospitalized with community-acquired pneumonia
Use of intravenous tocilizumab in pregnancy for severe coronavirus disease 2019 pneumonia: two case reports
Changing patterns and clinical outcomes of hospitalized patients with COVID-19 severe pneumonia treated with remdesivir according to vaccination status: results from a real-world retrospective study
Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients
Tocilizumab improves 28-day survival in hospitalized patients with severe COVID-19: an open label, prospective study
Tocilizumab for severe COVID-19 pneumonia: Experience from 5 geriatric Chinese patients with 6 months follow-up
Correction to: Changing patterns and clinical outcomes of hospitalized patients with COVID‑19 severe pneumonia treated with remdesivir according to vaccination status: results from a real‑world retrospective study
Validation of risk scores for prediction of severe pneumonia in kidney transplant recipients hospitalized with community-acquired pneumonia
Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience
A Case Series of Severe Hospitalized COVID-19 Patients Treated with Tocilizumab and Glucocorticoids: A Report from Saudi Arabian Hospital
Factors determining the outcome of children hospitalized with severe pneumonia
Respiratory viruses from hospitalized children with severe pneumonia in the Philippines
Age-specific risk factors of severe pneumonia among pediatric patients hospitalized with community-acquired pneumonia
Use of intravenous tocilizumab in pregnancy for severe coronavirus disease 2019 pneumonia: two case reports
Changing patterns and clinical outcomes of hospitalized patients with COVID-19 severe pneumonia treated with remdesivir according to vaccination status: results from a real-world retrospective study
Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients
Tocilizumab improves 28-day survival in hospitalized patients with severe COVID-19: an open label, prospective study
Tocilizumab for severe COVID-19 pneumonia: Experience from 5 geriatric Chinese patients with 6 months follow-up
Correction to: Changing patterns and clinical outcomes of hospitalized patients with COVID‑19 severe pneumonia treated with remdesivir according to vaccination status: results from a real‑world retrospective study
Validation of risk scores for prediction of severe pneumonia in kidney transplant recipients hospitalized with community-acquired pneumonia
Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience